Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app save kidneys in diabetes?

NCT ID NCT07836556

Disease control Sponsor: Universiti Sultan Zainal Abidin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 23, 2026 · Last updated Sep 24, 2026 · Updated 1 time

Summary

Researchers test whether a mobile app that teaches health literacy helps adults with diabetes and chronic kidney disease. The trial enrolls 102 people in Kuala Terengganu, Malaysia, who have stage I to IV kidney disease and use an Android smartphone. Half receive the MyNEPHRO app with weekly lessons, and half receive usual care. The team measures health literacy, quality of life, blood sugar (HbA1c), and kidney function (eGFR) over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a mobile app health literacy module called MyNEPHRO
What this could lead to
If the app helps, it could offer a low-cost way for people with diabetes and kidney disease to learn skills that slow kidney damage and improve daily life.
What could go wrong
This is a small, short trial in one region of Malaysia, so results may not apply elsewhere. An app alone may not change kidney function or blood sugar if people do not use it regularly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 102 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: (1) are more than 18 years old who live, work, or study in Kuala Terengganu, Terengganu, Malaysia 2) are diabetics with CKD (Stages I- IV) as diagnosed by their physicians (3) own a smartphone (only Android) (4) are fluent in the Malay language; and (5) are willing to participate in programme. Exclusion Criteria: 1. those having comorbid conditions affecting the kidney such as nephrolithiasis 2. those participating in additional health education programmes or interventional research 3. those who are already using a mobile application for self-management. 4. Those who had been admitted for any renal problems for the past one month.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus Health literacy Quality of life Renal insufficiency, chronic

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.